For my eye, OTC drops aren’t enough.
Alison Tendler, MD Eye Doctor

Topical cyclosporine A(tCSA) 0.05% ophthalmic emulsion is an immunosuppressant, marketed in the United States by Allergan under the trade name Restasis. Approved as a prescription product by the U.S. Food and Drug Administration in 2002, the drug decreases surface inflammation. It is thought to work through inhibition of transcription factors required for cytokine production and T-lymphocyte maturation. – Wikipedia

Prevention January 2009